Changes in high-density lipoprotein-carried miRNA contribution to the plasmatic pool after consumption of dietary trans fat in healthy men

References

• Nestel P . Trans fatty acids: are its cardiovascular risks fully appreciated?Clin. Ther.36 ( 3 ), 315 – 321 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dawczynski C , LorkowskiS . Trans-fatty acids and cardiovascular risk: does origin matter?Expert Rev. Cardiovasc. Ther.1 – 5 ( 2016 ).
   Google Scholar
• Lamarche B , CoutureP . Dietary fatty acids, dietary patterns, and lipoprotein metabolism . Curr. Opin. Lipidol.26 ( 1 ), 42 – 47 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Brouwer IA , WandersAJ , KatanMB . Trans fatty acids and cardiovascular health: research completed?Eur. J. Clin. Nutr.67 ( 5 ), 541 – 547 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sharrett AR , BallantyneCM , CoadySAet al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study . Circulation104 ( 10 ), 1108 – 1113 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Assmann G , SchulteH , Von EckardsteinA , HuangY . High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport . Atherosclerosis124 ( Suppl. ), S11 – S20 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Nicholls SJ , PuriR , WolskiKet al. Effect of the bet protein inhibitor, RVX-208, on progression of coronary atherosclerosis: results of the Phase IIb, randomized, double-blind, multicenter, assure trial . Am. J. Cardiovasc. Drugs.16 ( 1 ), 55 – 65 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Barter PJ , CaulfieldM , ErikssonMet al. Effects of torcetrapib in patients at high risk for coronary events . N. Engl. J. Med.357 ( 21 ), 2109 – 2122 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Schwartz GG , OlssonAG , AbtMet al. Effects of dalcetrapib in patients with a recent acute coronary syndrome . N. Engl. J. Med.367 ( 22 ), 2089 – 2099 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tardif AC , BallantyneCM , BarterPet al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial . Eur. Heart J.35 ( 46 ), 3277 – 3286 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Voight BF , PelosoGM , Orho-MelanderMet al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study . Lancet.380 ( 9841 ), 572 – 580 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Khera AV , CuchelM , De La Llera-MoyaMet al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis . N. Engl. J. Med.364 ( 2 ), 127 – 135 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• De La Llera-Moya M , Drazul-SchraderD , AsztalosBF , CuchelM , RaderDJ , RothblatGH . The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages . Arterioscler. Thromb. Vasc. Biol.30 ( 4 ), 796 – 801 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Asztalos BF , TaniM , SchaeferEJ . Metabolic and functional relevance of HDL subspecies . Curr. Opin. Lipidol.22 ( 3 ), 176 – 185 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Riwanto M , RohrerL , Von EckardsteinA , LandmesserU . Dysfunctional HDL: from structure–function-relationships to biomarkers . Handb. Exp. Pharmacol.224 , 337 – 366 ( 2015 ).
   PubMedGoogle Scholar
• Desgagne V , BouchardL , GuerinR . microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application . Clin. Chem. Lab. Med55 ( 5 ), 667 – 686 ( 2016 ).
   Web of Science ®Google Scholar
• Friedman RC , FarhKK , BurgeCB , BartelDP . Most mammalian mRNAs are conserved targets of microRNAs . Genome. Res.19 ( 1 ), 92 – 105 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gao Y , PengJ , RenZet al. Functional regulatory roles of microRNAs in atherosclerosis . Clin. Chim. Acta.460 , 164 – 171 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Guay C , RegazziR . Role of islet microRNAs in diabetes: which model for which question?Diabetologia58 ( 3 ), 456 – 463 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rottiers V , NaarAM . MicroRNAs in metabolism and metabolic disorders . Nat. Rev. Mol. Cell. Biol.13 ( 4 ), 239 – 250 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Vickers KC , PalmisanoBT , ShoucriBM , ShamburekRD , RemaleyAT . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins . Nat. Cell. Biol.13 ( 4 ), 423 – 433 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tabet F , VickersKC , Cuesta TorresLFet al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells . Nat. Commun.5 , 3292 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wagner J , RiwantoM , BeslerCet al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs . Arterioscler. Thromb. Vasc. Biol.33 ( 6 ), 1392 – 1400 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Niculescu LS , SimionescuN , SandaGMet al. MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients . PLoS ONE10 ( 10 ), e0140958 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Desgagne V , GuaySP , GuerinRet al. Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men – an exploratory study . Epigenetics11 ( 6 ), 438 – 448 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tabet F , Cuesta TorresLF , OngKLet al. High-density lipoprotein-associated mir-223 is altered after diet-induced weight loss in overweight and obese males . PLoS ONE11 ( 3 ), e0151061 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Motard-Belanger A , CharestA , GrenierGet al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease . Am. J. Clin. Nutr.87 ( 3 ), 593 – 599 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Labonte ME , CoutureP , PaquinP , ChouinardY , LemieuxS , LamarcheB . Comparison of the impact of trans fatty acids from ruminant and industrial sources on surrogate markers of cholesterol homeostasis in healthy men . Mol. Nutr. Food. Res.55 ( Suppl. 2 ), S241 – S247 ( 2011 ).
   PubMedGoogle Scholar
• Havel RJ , EderHA , BragdonJH . The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum . J. Clin. Invest.34 ( 9 ), 1345 – 1353 ( 1955 ).
   PubMed Web of Science ®Google Scholar
• Kirstein P , CarlsonK . Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma . Clin. Chim. Acta113 ( 2 ), 123 – 134 ( 1981 ).
   PubMed Web of Science ®Google Scholar
• Hafiane A , GenestJ . High-density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk . BBA Clin.3 , 175 – 188 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method . Methods25 ( 4 ), 402 – 408 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• El Harchaoui K , ArsenaultBJ , FranssenRet al. High-density lipoprotein particle size and concentration and coronary risk . Ann. Intern. Med.150 ( 2 ), 84 – 93 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Benjamini Y , HochbergY . Controlling the false discovery rate: a practical and powerful approach to multiple testing . J. R. Stat. Soc. Series B Methodol.57 ( 1 ), 289 – 300 ( 1995 ).
   Google Scholar
• Vlachos IS , ZagganasK , ParaskevopoulouMDet al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support . Nucleic Acids Res.43 ( W1 ), W460 – W466 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) . A global brief on hypertension: silent killer, global public health crisis. Section II: hypertension; the basic facts . ( 2013 ). http://ish-world.com/downloads/pdf/global_brief_hypertension.pdf
   Google Scholar
• Genest J , McphersonR , FrohlichJet al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations . Can. J. Cardiol.25 ( 10 ), 567 – 579 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yeh ET , WillersonJT . Coming of age of C-reactive protein: using inflammation markers in cardiology . Circulation107 ( 3 ), 370 – 371 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Creemers EE , TijsenAJ , PintoYM . Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?Circ. Res.110 ( 3 ), 483 – 495 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Boon RA , VickersKC . Intercellular transport of microRNAs . Arterioscler. Thromb. Vasc. Biol.33 ( 2 ), 186 – 192 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Raposo G , StoorvogelW . Extracellular vesicles: exosomes, microvesicles, and friends . J. Cell. Biol.200 ( 4 ), 373 – 383 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang X , DongH , TianY . miRNA biology in pathological processes . In : MicroRNA Detection and Pathological Functions . Springer-Verlag Berlin Heidelberg , Berlin, Germany , 7 – 22 ( 2015 ).
   Google Scholar
• Kirschner MB , KaoSC , EdelmanJJet al. Haemolysis during sample preparation alters microRNA content of plasma . PLoS ONE6 ( 9 ), e24145 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xu X , LiS , LinYet al. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1 . J. Transl. Med.11 , 276 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Deng D , WangL , ChenYet al. MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma . Cancer Sci.107 ( 7 ), 899 – 907 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Qin Z , WangPY , SuDF , LiuX . miRNA-124 in immune system and immune disorders . Front. Immunol.7 , 406 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Yu A , ZhangT , DuanHet al. MiR-124 contributes to M2 polarization of microglia and confers brain inflammatory protection via the C/EBP-alpha pathway in intracerebral hemorrhage . Immunol. Lett.182 , 1 – 11 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zhang H , LiuR , DengTet al. The microRNA-124-iGluR2/3 pathway regulates glucagon release from alpha cells . Oncotarget7 ( 17 ), 24734 – 24743 ( 2016 ).
   PubMedGoogle Scholar
• He Y , JiangX , ChenJ . The role of miR-150 in normal and malignant hematopoiesis . Oncogene33 ( 30 ), 3887 – 3893 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ying W , TsengA , ChangRCet al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions . Sci. Rep.6 , 20176 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Liu Z , YeP , WangSet al. MicroRNA-150 protects the heart from injury by inhibiting monocyte accumulation in a mouse model of acute myocardial infarction . Circ. Cardiovasc. Genet.8 ( 1 ), 11 – 20 ( 2015 ).
   PubMedGoogle Scholar
• Li J , ZhangS . microRNA-150 inhibits the formation of macrophage foam cells through targeting adiponectin receptor 2 . Biochem. Biophys. Res. Commun.476 ( 4 ), 218 – 224 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Stepicheva NA , SongJL . Function and regulation of microRNA-31 in development and disease . Mol. Reprod. Dev.83 ( 8 ), 654 – 674 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Iacomino G , RussoP , StillitanoIet al. Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I. Family study . Genes. Nutr.11 , 7 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Seyhan AA , Nunez LopezYO , XieHet al. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study . Sci. Rep.6 , 31479 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Villard A , MarchandL , ThivoletC , RomeS . Diagnostic value of cell-free circulating microRNAs for obesity and Type 2 diabetes: a meta-analysis . J. Mol. Biomark. Diag.6 ( 6 ), 251 ( 2015 ).
   PubMedGoogle Scholar
• Kusnierz-Cabala B , NowakE , SporekMet al. Serum levels of unique miR-551–5p and endothelial-specific miR-126a-5p allow discrimination of patients in the early phase of acute pancreatitis . Pancreatology15 ( 4 ), 344 – 351 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pirola CJ , Fernandez GianottiT , CastanoGOet al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis . Gut64 ( 5 ), 800 – 812 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Marchand L , JalabertA , MeugnierEet al. miRNA-375 a Sensor of glucotoxicity is altered in the serum of children with newly diagnosed Type 1 diabetes . J. Diabetes. Res. 2016 , 1869082 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Li X . MiR-375, a microRNA related to diabetes . Gene533 ( 1 ), 1 – 4 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bonnans C , ChouJ , WerbZ . Remodelling the extracellular matrix in development and disease . Nat. Rev. Mol. Cell. Biol.15 ( 12 ), 786 – 801 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fan D , CreemersEE , KassiriZ . Matrix as an interstitial transport system . Circ. Res.114 ( 5 ), 889 – 902 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Olin-Lewis K , BentonJL , RutledgeAC , BaskinDG , WightTN , ChaitA . Apolipoprotein E mediates the retention of high-density lipoproteins by mouse carotid arteries and cultured arterial smooth muscle cell extracellular matrices . Circ. Res.90 ( 12 ), 1333 – 1339 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Kothapalli D , LiuSL , BaeYHet al. Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening . Cell. Rep.2 ( 5 ), 1259 – 1271 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Camejo G , Hurt-CamejoE , WiklundO , BondjersG . Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis . Atherosclerosis139 ( 2 ), 205 – 222 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• O’brien KD , VuleticS , McDonaldTOet al. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis . Circulation108 ( 3 ), 270 – 274 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Pollard RD , BlessoCN , ZabalawiMet al. Procollagen C-endopeptidase enhancer protein 2 (PCPE2) reduces atherosclerosis in mice by enhancing scavenger receptor class B1 (SR-BI)-mediated high-density lipoprotein (HDL)-cholesteryl ester uptake . J. Biol. Chem.290 ( 25 ), 15496 – 15511 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mitchell GF , HwangSJ , VasanRSet al. Arterial stiffness and cardiovascular events: the Framingham Heart Study . Circulation121 ( 4 ), 505 – 511 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Krogager TP , NielsenLV , KahveciDet al. Hepatocytes respond differently to major dietary trans fatty acid isomers, elaidic acid and trans-vaccenic acid . Proteome Sci.13 , 31 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tan GW , KhooAS , TanLP . Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs . Sci. Rep.5 , 9430 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lee LW , ZhangS , EtheridgeAet al. Complexity of the microRNA repertoire revealed by next-generation sequencing . RNA16 ( 11 ), 2170 – 2180 ( 2010 ).
   PubMed Web of Science ®Google Scholar